PharmTech AI Pulse Check panelists explain why attribution, audit trails, and sign-off matter more than AI watermark detection for GxP quality teams.
|Articles|January 2, 2020
- Pharmaceutical Technology-01-02-2020
- Volume 44
- Issue 1
Production, Packaging, and Inspection
The NXT Series from ACG Group consists of the Protab 300 NXT, Protab 700 NXT, BMax NXT (pictured), KartonX NXT, and Verishield CS18 NXT machines for production, packaging, and inspection.
The NXT Series from ACG Group consists of the Protab 300 NXT, Protab 700 NXT, BMax NXT (pictured), KartonX NXT, and Verishield CS18 NXT machines for production, packaging, and inspection. The combined system includes tablet presses, blister and carton packing equipment, and serialization units for track-and-trace applications.
Each machine is designed with StealthDesign for maximized output and a minimized footprint; UltraHMI for high-precision, contamination-free machines; ExploreAR, an augmented reality solution that reduces production downtime, identifies and resolves maintenance issues, and keeps manufacturing moving at an optimized pace; and RevealiOT, a IIoT platform that allows for intermachine connectivity and efficient manufacturing processes through dashboards.
Articles in this issue
over 6 years ago
Human-Centered Work: How Pharma Can Move to a Blame-Free Cultureover 6 years ago
Public Opinion: Can Pharma Chart a New Course?almost 7 years ago
Pharma Regulation to be Shaped by Pricing and Production Issuesalmost 7 years ago
Can Policy Keep Pace with Science and Discoveries?almost 7 years ago
ReNu Single-Use Technology Cartridge Assembliesalmost 7 years ago
Sanitary Tumble Blenderalmost 7 years ago
Plastic Mixing Systemsalmost 7 years ago
US Maintains Lead in Drug Development Despite Fewer Approvals in 2019almost 7 years ago
Choices for Climbing the Career Ladderalmost 7 years ago
Optimizing Machine HealthRelated to this article
Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.
The FDA approves oral pritelivir for drug-resistant herpes sores in immunocompromised patients; what it means for antiviral development and manufacturing.
This week, drug formulation and manufacturing experts showcased their knowledge, and companies exhibited their products, at CPHI Milan.
FDA approves Teva’s Weltruza, a once-monthly subcutaneous olanzapine for schizophrenia whose copolymer depot eliminates post-injection monitoring.
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
Richard Jaenisch examines whether FDA's NAM pathway truly shortens drug pipelines or just shifts the evidentiary burden elsewhere.
Susan J. Schniepp, distinguished fellow with Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical, with Parexel, clear up some of the confusion about what does and does not need to be complied with regarding standards set by international pharmacopoeias.
Trending on Pharmaceutical Technology
1
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 2
2
PharmTech AI Pulse Check: Availability Bias Threatens AI Regulatory Reviews
3
Pritelivir Shifts Resistant Herpes Care from Intravenous to Oral
4
What the Olanzapine Depot Approval Means for CMC Teams
5